Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
recombinant follicle stimulating hormone
- Development stage
- Unknown
- Lead developer
- Merck KGaA
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Subcutaneous, Intramuscular
01
Overview
Recombinant follicle stimulating hormone (rFSH) is a synthetic form of the endogenous human follicle-stimulating hormone (FSH), produced using recombinant DNA technology. It is a key therapeutic agent in assisted reproductive technology (ART) used to stimulate the development of multiple follicles in the ovaries of women undergoing treatments such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). In the context of clinical research at Assiut University, rFSH is utilized in conventional high-dose gonadotropin protocols (typically 300-450 IU/day) to manage patients classified as 'poor responders' according to the Bologna criteria. The hormone works by binding to the follicle stimulating hormone receptor (FSHR) on granulosa cells, promoting follicular growth, maturation, and estrogen production.
- Brand names
- Gonal-fPuregonFollistimBemfolaOvaleapRekovelle
- Other names
- follitropin alfafollitropin betafollitropin deltarecombinant follicular stimulating hormone
02
Targets
FSHR (Follicle-stimulating hormone receptor)
Beyond the preview
Go deeper on recombinant follicle stimulating hormone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on recombinant follicle stimulating hormone.